Product Image
Invitrogen™

Kit de expresión direccional lentiviral ViraPower™ TOPO™

El kit de expresión ViraPower™ Lentiviral Directional TOPO™ incluye todos los componentes necesarios para generar lentivirus, incluido el kit deMás información
Have Questions?
Número de catálogoCantidad
K4950001 kit
Número de catálogo K495000
Precio (USD)
-
Cantidad:
1 kit
El kit de expresión ViraPower™ Lentiviral Directional TOPO™ incluye todos los componentes necesarios para generar lentivirus, incluido el kit de vectores, la línea celular 293FT y el kit de soporte.Combina las tecnologías TOPO™ lentiviral y direccional ViraPower™ de Invitrogen para facilitar la clonación rápida basada en PCR y la expresión de alto nivel a base de lentiviral de un gen objetivo en células de mamíferos divisorias y no divisorias.El vector pLenti6⁄V5-D-TOPO™ incluye el promotor de CMV para llevar a cabo una expresión constitutiva del gen diana y del marcador de selección de blasticidina y conseguir una selección estable en células de mamíferos.

Ventajas
• Expresión lentiviral de un gen diana en células de mamíferos que se dividen y no se dividen

Características clave
• Tecnología de clonación directa TOPO™
• Alto nivel de expresión constitutiva con un promotor de CMV
• Marcador de selección de blasticidina para conseguir una selección estable
• Etiqueta V5 C-terminal para la detección rápida

Contenido del kit
•Vector pLenti6⁄V5-D™-TOPO™
• ViraPower™ Kit de soporte Bsd lentiviral (K4970-00)
• 293FT Línea de células (R70007)
• E. coli químicamente competente One Shot™ Stbl3™ (C7373-03)

Related relacionados
•Kit de clonación pLenti6⁄V5™ Directional TOPO™ (K4955-10)
• Lentiviral ViraPower™ Gateway™ Kit de expresión (K4960-00)
• Kit de expresión ViraPower™ HiPerform™ Lentiviral TOPO™ (K5310-00)
• Kit pLenti6.3?V5™-TOPO™ TA Cloning™ Kit (K531520)

Para uso exclusivo en investigación.No está previsto para ningún uso terapéutico o de diagnóstico.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Sistema constitutivo o inducibleConstitutivo
Tipo de entregaLentivírico
Para utilizar con (aplicación)Expresión viral
Tipo de productoKit de expresión lentiviral
Cantidad1 kit
Agente de selección (eucariótico)Blasticidina
VectorVectores TOPO direccionales
Método de clonaciónTOPO direccional
Línea de productosOne Shot
PromotorCMV
Etiqueta de proteínaEtiqueta de epítopo V5
Unit SizeEach
Contenido y almacenamiento
Kit de clonación pLenti6⁄V5™ direccional TOPO™:
• Reactivos pLenti6⁄V5™ direccional TOPO™: -20 °C
E. coli químicamente competente One Shot™ Stbl3™:-80 °C

Kit de soporte lentiviral ViraPower™ Bsd:
• Mezcla de embalaje ViraPower™: -20 °C
• Lipofectamine™ 2000: 4 °C (NO congelar)
• Blasticidina: -20 °C
• Línea celular 293FT: nitrógeno líquido

Preguntas frecuentes

I used one of your lentiviral vectors but am observing cytotoxic effects after transduction. Can you please help?

Possible causes include:

- large volume of viral supernatant used for transduction
- cells sensitive to Polybrene regaent
- too much antibiotic used for selection
- antibiotic used too soon after tranduction
- gene of interest is toxic to cells

I transduced my lentiviral stock into my mammalian cell line but am getting poor expression of my gene of interest. What could have happened?

Poor expression could result from low transduction efficiency, too low of a MOI, too much antibiotic used for selection, usage of antibiotic too soon after transduction, harveting cells too soon after transduction, having a gene of interest that is toxic to cells, or rerrangement in the LTR regions of the expression construct plasmid DNA.

I transduced my lentiviral stock into my mammalian cell line but am getting no expression of my gene of interest. What could have gone wrong?

Here are some possible causes and solutions:
- Promoter silencing; CMV promoter is prone to silencing especially in mouse and rat cells, screen multiple antibiotic resistant clones and select the one with the highest expression levels
- Viral stocks stored incorrectly; aliquot and store at -80 degrees C, do not freeze/thaw more than 3 times

I prepared a lentiviral stock using one of your lentiviral vectors. I am trying to determine the titer using antibiotic selection but am not able to since the cells are very confluent and I am not getting antibiotic-resistant clones. Can you please offer some tips?

Here are some possible causes and solutions:

- Too little antibotic used for selection
- Selection performed on confluent cells; replate cells
- Viral supernatant not diluted sufficiently; titer lentivus using a wider range of 10-fold serial dilutions

I am using one of your lentiviral vectors and am getting a low lentiviral titer. Can you offer some troubleshooting tips?

Possible causes include:

- low transfection efficiency; Use a high-quality plasmid prep, 293FT cells under passage 16, ensure removal of Geneticin during transfection, ensure correct DNA:lipid ratio, and that cells are plated at the correct confluency
- transfected cells are not cultured in medium containing sodium pyruvate; this reagent provides an extra energy source for cells
- viral supernatant harvested too early; viral supernatants can generally be collected 48-72 hrs post-transfection
- viral supernatant too dilute; concentrate virus using CsCl purification
- viral supernatant frozen and thawed multiple times; 3 times should be the maximum freeze/thaw
- gene of interest is large; viral titers decrease as size of insert increases, inserts larger than 5.6 kb are not recommended
- rearrangement in the LTR region of the epxression construct plasmid DNA; use Stb3 cells for transformatin of the lentiviral construct
- poor choice of titering cell line; use HT1080 cells or similar cell line
- Polybrene reagent is not included during transduction; transduce lentiviral construct into cells in the presence of Polybrene reagent
- Lipofectamine reagent handled incorrectly; ensure proper storage and mix gently before use
- Use fluorescence micrscopy to check titer with HiPerform FastTiter lentivirus

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

Citations & References (7)

Citations & References
Abstract
RIP140-targeted repression of gene expression in adipocytes.
Authors:Christian M, Kiskinis E, Debevec D, Leonardsson G, White R, Parker MG,
Journal:Mol Cell Biol
PubMed ID:16227589
'Ligand-dependent repression of nuclear receptor activity forms a novel mechanism for regulating gene expression. To investigate the intrinsic role of the corepressor RIP140, we have monitored gene expression profiles in cells that express or lack the RIP140 gene and that can be induced to undergo adipogenesis in vitro. In contrast ... More
Congenital Disorder of Glycosylation Id (CDG-Id) Presenting with Hyperinsulinemic Hypoglycemia and Islet Cell Hyperplasia.
Authors:Sun L, Eklund EA, Chung WK, Wang C, Cohen J, Freeze HH,
Journal:J Clin Endocrinol Metab
PubMed ID:15840742
'Context: Inborn errors in protein glycosylation such as the congenital disorders of glycosylation (CDG) generate multifaceted syndromes that impair many organ systems. We here report the diagnosis of the third known patient with CDG-Id. Results: The patient''s phenotype was extremely severe and she succumbed at nineteen days of age. Leading ... More
Group VIB Ca2+-independent Phospholipase A2{gamma} Promotes Cellular Membrane Hydrolysis and Prostaglandin Production in a Manner Distinct from Other Intracellular Phospholipases A2.
Authors:Murakami M, Masuda S, Ueda-Semmyo K, Yoda E, Kuwata H, Takanezawa Y, Aoki J, Arai H, Sumimoto H, Ishikawa Y, Ishii T, Nakatani Y, Kudo I,
Journal:J Biol Chem
PubMed ID:15695510
'Although group VIA Ca(2+)-independent phospholipase A(2)beta (iPLA(2)beta) has been implicated in various cellular events, the functions of other iPLA(2) isozymes remain largely elusive. In this study, we examined the cellular functions of group VIB iPLA(2)gamma. Lentiviral transfection of iPLA(2)gamma into HEK293 cells resulted in marked increases in spontaneous, stimulus-coupled, and ... More
A Novel Diacylglycerol-lactone Shows Marked Selectivity in Vitro among C1 Domains of Protein Kinase C (PKC) Isoforms {alpha} and {delta} as Well as Selectivity for RasGRP Compared with PKC{alpha}.
Authors:Pu Y, Perry NA, Yang D, Lewin NE, Kedei N, Braun DC, Choi SH, Blumberg PM, Garfield SH, Stone JC, Duan D, Marquez VE,
Journal:J Biol Chem
PubMed ID:15923197
'Although multiple natural products are potent ligands for the diacylglycerol binding C1 domain of protein kinase C (PKC), RasGRP, and related targets, the high conservation of C1 domains has impeded the development of selective ligands. We characterized here a diacylglycerol-lactone, 130C037, emerging from a combinatorial chemical synthetic strategy, which showed ... More
Methionine sulfoxide reductase A is important for lens cell viability and resistance to oxidative stress.
Authors:Kantorow M, Hawse JR, Cowell TL, Benhamed S, Pizarro GO, Reddy VN, Hejtmancik JF,
Journal:Proc Natl Acad Sci U S A
PubMed ID:15199188
Age-related cataract, an opacity of the eye lens, is the leading cause of visual impairment in the elderly, the etiology of which is related to oxidative stress damage. Oxidation of methionine to methionine sulfoxide is a major oxidative stress product that reaches levels as high as 60% in cataract while ... More